UCBME Current Grants
AHA: AHA 0815371D, Balaji, Swathi, "Angiogenic microenvironment to augment diabetes-associated deficiency in vascularization in the db/db mouse model" (7/ 1/ 2008 to 6/ 30/ 2010) $ 42,100
NIH: 5 R01 AR46574-09, Butler, David, "In Vitro Mechanical Stimulation to Enhance Tendon Repair" (11/1/ 1999 to 8/ 31/ 2010) $ 1,953,580
NIH: 1R21 EB004859-02, Butler, David, ""Robotic Simulation: Tissue Function with In Vivo Motions"" (3/1/ 2006 to 2/ 28/ 2009) $ 395,803"
LifeCell: Butler, David, "Design and Development of ACL Prosthesis: A Collaborative Project between the University of Cincinnati and LifeCell, Inc." (3/ 1/ 2008 to 2/ 28/ 2009) $ 80,624
NIH: 7 R01 EB003730-04, Guo, Peixuan, "Nanotube and nanogold to gear phi29 DNA packaging motor" (7/1/ 2007 to 6/30/2009) $ 259,468
NIH: 5 R01 GM059944-09, Guo, Peixuan, "Structure and Function of Phi29 hexameric pRNA" (8/ 1/ 1999 to 11/ 30/ 2009) $715,552
NIH: 5 PN2 EY018230-03, Guo, Peixuan, "Phi29 DNA-Packaging Motor for Nanomedicine" (7/ 1/ 2007 to 9/ 29/ 2008) $5,682,276
Kylin: Guo, Peixuan, "Synthesis of therapeutic pRNA/siRNA for trials in cells culture and animals" (12/1/ 2007 to 11/30/2010) $ 534,408
Ft. Dodge: Guo, Peixuan, "Evaluation of the surface receptor of canine cancer cell lines" (1/ 1/ 2009 to 12/31/2011) $ 439,118
NSF: NSF IIP-0652208, Montemagno, Carlo, "Minimally Invasive Medical Technology Center (MIMTeC)" (2/ 15/ 2007 to 1/31/2012) $ 312,418
P&G, Ehticon, Cordis: NSF IIP-0652208 INDUSTRY, Montemagno, Carlo, "Minimally Invasive Medical Technology Center (MIMTeC)" (6/ 1/ 2007 to 5/ 31/ 2010) $ 400,000
University of Texas Health Science Center: 2 R56 HL059586-08, Holland, Christy, "Targeted Liposomes for Acoustic Cardiovascular Imaging" (9/15/2003 to 5/31/2009) $ 572,701
NIH: 2R01NS047603-05, Holland, Christy, "Ultrasound-Assisted Thrombolysis for Stroke Therapy" (07/ 1/ 2004 to 12/30/2013) $ 5,503,528
University of Texas Health Science Center: UTHC SUB NIH 1 R01 HL74002-04, Holland, Christy, "Echogenic Targeted Liposomes:Transfection/Drug Delivery" (4/1/ 2006 to 3/31/2009) $ 632,353
The Neuroscience Institute: TNI 2007 HOLLAND, Holland, Christy, "Ultrasound Enhanced Thrombolysis in an Exvivo Rat Carotid Artery" (1/ 1/ 2007 to 12/ 31/ 2008) $ 23,407
NIH: 1 R21 EB005042-02, Lee, Jing-Huei, "Active acoustic noise cancellation for MRI" (5/ 5/ 2006 to 4/ 30/ 2009) $ 258,365
University Research Center: URC, Lee, Jing-Huei, "URC Interdisciplinary Grant" (3/ 1/ 2008 to 2/29/2009) $ 12,500
Ardent Sound: ARDENT SUB NIH 1 R43 CA124283-01, Mast, T. Douglas, "Integrated Image-Guided Ultrasound Ablation System for Cancer Management" (9/ 26/ 2006 to 8/ 31/ 2009) $ 105,311
University of Cincinnati: UC, Mast, T. Douglas, "Passive Cavitation Imaging for Guidance and Control of Ultra-sound Ablation" (3/ 10/ 2008 to 3/ 9/ 2009) $ 30,000
University of Cincinnati: UC, Mast, T. Douglas, "Controlled occlusion of large arteries and veins in rabbits with extracorporeal high intensity focused ultrasound" (7/ 1/ 2008 to 6/ 30/ 2009) $ 30,181
NIH: 1 R21 EB008483-01A1, Mast, T. Douglas, "Passive Cavitation Imaging for Guidance and Control of Ultrasound Ablation" (2/ 1/ 2009 to 1/ 31/ 2011) $ 388,930
NSF: NSF EEC-0649914, Montemagno, Carlo, "Research Cooperative Education" (9/ 15/ 2006 to 2/ 28/ 2009) $ 200,000
AHA: AHA #0765425B YR 2, Narmoneva, Daria, "Endothelial-Fibroblast Interactions in Vascular Tissue Engineering" (7/1/2008 to 6/ 30/ 2009) $ 121,000
NIH: 1 R21 DK078814-01A1, Narmoneva, Daria, "Angiogenic Peptide Scaffolds to Enhance Diabetic Wound Healing" (7/15/2008 to 6/30/ 2009) $ 246,754
Repironics: Privitera, Mary Beth, "Mask of the Future for People with Sleep Apnea" (9/ 20/ 2006 to 3/ 9/ 2009) $ 25,036
RADLyn: Privitera, Mary Beth, "Multi-function Stylet" (9/ 1/ 2008 to 8/ 31/ 2009) $ 50,000
NIH: POC-CEN, Privitera, Mary Beth, "Point of Care Center for Emerging Neurotechnologies (POC-CENT)" (9/30/ 2007 to 6/30/2012) $ 48,018
UCBME Pending Grant Proposals
NIH: 5 R01 EB003730, Guo, Peixuan, "Assembly of phi29 pRNA nanoparticles for siRNA dilivery to prostate cancer cells" (4/1/2009 to 3/31/2013) $ 1,737,539
AHA: Hurley, Jennifer, "Development of MMP-2/Peptide Nanoscaffold Delivery System for Treatment of Diabetic Cardiomyopathy" (7/ 1/ 2009 to 6/ 30/ 2011) $ 4,780
University of Texas Health Science Center: UTHSC SUB NIH PPG, Holland, Christy, "Ultrasound-enhanced stem cell and targeted drug delivery" (12/ 1/ 2009 to 11/ 30/ 2014) $ 3,272,832
NIH: Butler, David, "A Developmentally-Based Tissue Engineering Approach to Improve Tendon Repair" (7/1/2009 to 6/30/2014) $ 3,769,300
NIH: Shearn, Jason, "Establishing Design Criteria and Large Animal Model for Evaluation of ACL Repair" (7/1/2009 to 6/30/2013) $ 1,504,727
University of Texas Health Science Center: UTHSC via NIH, Holland, Christy, " Echogenic Targeted Liposomes: Trasfection/Drug Delivery" (7/ 1/ 2009 to 6/ 30/ 2014) $ 1,095,782
NIH: Montemagno, Carlo, "REU Site for Engineering Tomorrow" (1/ 1/ 2009 to 12/ 31/ 2011) $ 389,539
NIH: Narmoneva, Daria, "Nanoscaffold technology to restore diabetic wound microenvironment and enhance healing." (4/1/2010 to 3/31/ 2014) $ 1,384,769
2901 Campus Drive ML 0048 Cincinnati, OH 45221-0048 Phone: 513-556-4171 Fax: 513-556-4162 Email: bme@uc.edu
